Cargando…
The expression level of the transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT) determines cellular survival after radiation treatment
BACKGROUND: Tumour hypoxia promotes radioresistance and is associated with poor prognosis. The transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT), also designated as Hypoxia-inducible factor (HIF)-1β, is part of the HIF pathway which mediates cellular adaptations to oxygen de...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647475/ https://www.ncbi.nlm.nih.gov/pubmed/26572229 http://dx.doi.org/10.1186/s13014-015-0539-9 |
_version_ | 1782401106845892608 |
---|---|
author | Mandl, Markus Lieberum, Maria- Katharina Dunst, Juergen Depping, Reinhard |
author_facet | Mandl, Markus Lieberum, Maria- Katharina Dunst, Juergen Depping, Reinhard |
author_sort | Mandl, Markus |
collection | PubMed |
description | BACKGROUND: Tumour hypoxia promotes radioresistance and is associated with poor prognosis. The transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT), also designated as Hypoxia-inducible factor (HIF)-1β, is part of the HIF pathway which mediates cellular adaptations to oxygen deprivation and facilitates tumour progression. The subunits HIF-1α and ARNT are key players within this pathway. HIF-1α is regulated in an oxygen-dependent manner whereas ARNT is considered to be constitutively expressed. However, there is mounting evidence that certain tumour cells are capable to elevate ARNT in hypoxia which suggests a survival benefit. Therefore the objective of this study was to elucidate effects of an altered ARNT expression level on the cellular response to radiation. METHODS: Different human cell lines (Hep3B, MCF-7, 786-Owt, 786-Ovhl, RCC4wt and RCC4vhl) originating from various tumour entities (Hepatocellular carcinoma, breast cancer and renal cell carcinoma respectively) were X-irradiated using a conventional linear accelerator. Knockdown of ARNT expression was achieved by transient siRNA transfection. Complementary experiments were performed by forced ARNT overexpression using appropriate plasmids. Presence/absence of ARNT protein was confirmed by Western blot analysis. Clonogenic survival assays were performed in order to determine cellular survival post irradiation. Statistical comparison of two groups was achieved by the unpaired t-test. RESULTS: The results of this study indicate that ARNT depletion renders tumour cells susceptible to radiation whereas overexpression of this transcription factor confers radioresistance. CONCLUSIONS: These findings provide evidence to consider ARNT as a drug target and as a predictive marker in clinical applications concerning the response to radiation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13014-015-0539-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4647475 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46474752015-11-18 The expression level of the transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT) determines cellular survival after radiation treatment Mandl, Markus Lieberum, Maria- Katharina Dunst, Juergen Depping, Reinhard Radiat Oncol Research BACKGROUND: Tumour hypoxia promotes radioresistance and is associated with poor prognosis. The transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT), also designated as Hypoxia-inducible factor (HIF)-1β, is part of the HIF pathway which mediates cellular adaptations to oxygen deprivation and facilitates tumour progression. The subunits HIF-1α and ARNT are key players within this pathway. HIF-1α is regulated in an oxygen-dependent manner whereas ARNT is considered to be constitutively expressed. However, there is mounting evidence that certain tumour cells are capable to elevate ARNT in hypoxia which suggests a survival benefit. Therefore the objective of this study was to elucidate effects of an altered ARNT expression level on the cellular response to radiation. METHODS: Different human cell lines (Hep3B, MCF-7, 786-Owt, 786-Ovhl, RCC4wt and RCC4vhl) originating from various tumour entities (Hepatocellular carcinoma, breast cancer and renal cell carcinoma respectively) were X-irradiated using a conventional linear accelerator. Knockdown of ARNT expression was achieved by transient siRNA transfection. Complementary experiments were performed by forced ARNT overexpression using appropriate plasmids. Presence/absence of ARNT protein was confirmed by Western blot analysis. Clonogenic survival assays were performed in order to determine cellular survival post irradiation. Statistical comparison of two groups was achieved by the unpaired t-test. RESULTS: The results of this study indicate that ARNT depletion renders tumour cells susceptible to radiation whereas overexpression of this transcription factor confers radioresistance. CONCLUSIONS: These findings provide evidence to consider ARNT as a drug target and as a predictive marker in clinical applications concerning the response to radiation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13014-015-0539-9) contains supplementary material, which is available to authorized users. BioMed Central 2015-11-16 /pmc/articles/PMC4647475/ /pubmed/26572229 http://dx.doi.org/10.1186/s13014-015-0539-9 Text en © Mandl et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Mandl, Markus Lieberum, Maria- Katharina Dunst, Juergen Depping, Reinhard The expression level of the transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT) determines cellular survival after radiation treatment |
title | The expression level of the transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT) determines cellular survival after radiation treatment |
title_full | The expression level of the transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT) determines cellular survival after radiation treatment |
title_fullStr | The expression level of the transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT) determines cellular survival after radiation treatment |
title_full_unstemmed | The expression level of the transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT) determines cellular survival after radiation treatment |
title_short | The expression level of the transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT) determines cellular survival after radiation treatment |
title_sort | expression level of the transcription factor aryl hydrocarbon receptor nuclear translocator (arnt) determines cellular survival after radiation treatment |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647475/ https://www.ncbi.nlm.nih.gov/pubmed/26572229 http://dx.doi.org/10.1186/s13014-015-0539-9 |
work_keys_str_mv | AT mandlmarkus theexpressionlevelofthetranscriptionfactorarylhydrocarbonreceptornucleartranslocatorarntdeterminescellularsurvivalafterradiationtreatment AT lieberummariakatharina theexpressionlevelofthetranscriptionfactorarylhydrocarbonreceptornucleartranslocatorarntdeterminescellularsurvivalafterradiationtreatment AT dunstjuergen theexpressionlevelofthetranscriptionfactorarylhydrocarbonreceptornucleartranslocatorarntdeterminescellularsurvivalafterradiationtreatment AT deppingreinhard theexpressionlevelofthetranscriptionfactorarylhydrocarbonreceptornucleartranslocatorarntdeterminescellularsurvivalafterradiationtreatment AT mandlmarkus expressionlevelofthetranscriptionfactorarylhydrocarbonreceptornucleartranslocatorarntdeterminescellularsurvivalafterradiationtreatment AT lieberummariakatharina expressionlevelofthetranscriptionfactorarylhydrocarbonreceptornucleartranslocatorarntdeterminescellularsurvivalafterradiationtreatment AT dunstjuergen expressionlevelofthetranscriptionfactorarylhydrocarbonreceptornucleartranslocatorarntdeterminescellularsurvivalafterradiationtreatment AT deppingreinhard expressionlevelofthetranscriptionfactorarylhydrocarbonreceptornucleartranslocatorarntdeterminescellularsurvivalafterradiationtreatment |